Across TCGA pan-cancer cohorts, PPP1R21 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated PPP1R21 data layer compared with 8 for mutation status and 5 for mass-spec protein.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher PPP1R21 RNA is associated with better overall survival. In most high-consensus cancer types, elevated PPP1R21 expression acts as an unfavorable survival marker, although some lineages such as KIRC and THCA show a favorable association.
KIRC, THCA, and ACC are the cancer types where PPP1R21 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.